Home    Back

Hourly dosing of the nychtemeral secretion of melatonin    (DrugBank: Melatonin)

1 disease
IDDisease name (Link within this page)Number of trials
202Smith-Magenis syndrome1

202. Smith-Magenis syndrome    [ 10 clinical trials,   10 drugs,   (DrugBank: 4 drugs),   4 drug target genes,   6 drug target pathways]
Searched query = "Smith-Magenis syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 10 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT03492970
(ClinicalTrials.gov)		March 7, 20181/3/2018Melatonin in Adults With SMSCharacterization of Behavioral Disorders and 24 H-melatonin Level in Adults With Smith Magenis SyndromeSmith Magenis SyndromeBiological: Hourly dosing of the nychtemeral secretion of melatoninHôpital le VinatierHospices Civils de LyonCompleted18 Years65 YearsAll10N/AFrance